Organization and Summary of Significant Accounting Policies - Seelos Merger Agreement (Q3) (Details)	1 Months Ended
Apr. 30, 2018 Clinicaltrial
Accounting Policies [Abstract]
Number of Phase 3 clinical efficacy trials required	2

Research And Development, Number Of Phase 3 Clinical Efficacy Trials Required

No definition available.

Name:	apri_ResearchAndDevelopmentNumberOfPhase3ClinicalEfficacyTrialsRequired
Namespace Prefix:	apri_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration